Cargando…
The impact of COVID‐19 on pregnancy and therapeutic drug development
Emerging data show that pregnant women with COVID‐19 are at significantly higher risk of severe outcomes compared with non‐pregnant women of similar age. This review discusses the invaluable insight revealed from vaccine clinical trials in women who were vaccinated and inadvertently became pregnant...
Autores principales: | Abbas‐Hanif, Allyah, Rezai, Homira, Ahmed, Syed Faraz, Ahmed, Asif |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8239854/ https://www.ncbi.nlm.nih.gov/pubmed/34085281 http://dx.doi.org/10.1111/bph.15582 |
Ejemplares similares
-
MZe786, a hydrogen sulfide-releasing aspirin prevents preeclampsia in heme oxygenase-1 haplodeficient pregnancy under high soluble flt-1 environment
por: Rezai, Homira, et al.
Publicado: (2020) -
MZe786 Rescues Cardiac Mitochondrial Activity in High sFlt-1 and Low HO-1 Environment
por: Sanchez-Aranguren, Lissette Carolina, et al.
Publicado: (2020) -
Hydrogen sulfide releasing molecule MZe786 inhibits soluble Flt-1 and prevents preeclampsia in a refined RUPP mouse model
por: Saif, Jaimy, et al.
Publicado: (2020) -
Bioenergetic effects of hydrogen sulfide suppress soluble Flt-1 and soluble endoglin in cystathionine gamma-lyase compromised endothelial cells
por: Sanchez-Aranguren, Lissette Carolina, et al.
Publicado: (2020) -
Correlation between psychiatric impact of COVID-19 during pregnancy and fetal outcomes in Egyptian women
por: Ahmed, Gellan k., et al.
Publicado: (2022)